Current Drug Targets (CDT)

Current Drug Targets is an international, peer reviewed scientific journal that focuses on the identification, characterization, and validation of molecular and cellular targets for drug discovery and development. The journal serves as a dedicated platform for researchers, clinicians, and pharmaceutical professionals to explore advances in the understanding of disease mechanisms and the corresponding therapeutic targets that can be modulated to treat various pathological conditions. By emphasizing the translation of basic biological research into drug discovery applications, the journal bridges the gap between molecular biology, medicinal chemistry, pharmacology, and clinical therapeutics. The scope of the journal includes receptor and enzyme targets, signal transduction pathways, genetic and epigenetic regulators, and other molecular entities relevant to drug design. It publishes comprehensive review articles, original research, and thematic issues that provide insights into emerging targets, novel drug modalities, and strategies for improving target selectivity and efficacy. Current Drug Targets also addresses challenges in target validation, high throughput screening, and structure based drug design, highlighting both preclinical and clinical perspectives. By disseminating authoritative reviews authored by experts in the field, the journal fosters informed decision making and guides the development of safer and more effective therapeutics. It is an essential resource for pharmaceutical scientists, academic researchers, and industry professionals seeking up to date knowledge on target based drug discovery and translational research

Current Drug Targets (CDT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Clinical Biochemistry, Drug Discovery, Pharmacology, Molecular Medicine, Pharmaceutical and medicinal chemists, Molecular biologists , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1389-4501, E-ISSN: 1873-5592, Established: 2026, Impact Factor: 2.5
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE